The industry is devoting all its resources to finding a vaccine, but we should not be complacent about the need to invest in future innovation, says Bernard Mallee

Mary Buckley, IDA Ireland, outlines key findings in the IDA’s 2015-19 strategy review.

Here is a selection of people who have just begun interesting new roles with companies in Ireland.

Procter & Gamble’s more optimistic forecast for the current year was offset by a revenue miss, a sign that analysts are setting a high bar for quarterly earnings with stocks at record highs.

The main Irish arm of orthopaedic medical device manufacturer, DePuy recorded pre-tax losses of €3.45bn in 2018.

There were her two expeditions to Everest which called on ambition and a willingness to motivate herself and others on the 7,000 metres and 6,500 metres climbs.

One of the largest industrial lettings in the Cork area in ten years has been confirmed this week.

The three largest US drug distributors and a major generic-drug manufacturer have agreed to pay more than $250m (€225m) to settle the first federal trial over the companies’ role in fuelling the US opioid epidemic.

Johnson & Johnson (J&J) said it would recall a single lot of its baby powder in the US after the regulator, the Food and Drug Administration, found trace amounts of asbestos in samples taken from a bottle bought online.

Helen Kelleher talks to Ken Murphy of CareerWise Recruitment

Johnson & Johnson (J&J) has offered to pay $4bn (€3.6bn) to settle all claims accusing the company of helping fuel the US opioid epidemic, as part of a potentially larger deal involving drugmakers and distributors that could top $20bn.

Johnson & Johnson (J&J) boosted its profit forecast for the year after posting better-than-expected quarterly earnings on stronger prescription sales of its psoriasis treatment Stelara and cancer drug Imbruvica.

Paschal Donohoe took as his Budget 2020 baseline scenario the hardest possible Brexit with the UK crashing out of the EU

Swiss pharmaceutical firms Novartis and Lonza separately deepened their push into so-called biosimilars, betting cheaper copies of name-brand drugs will make headway among cost-conscious governments.

So that’s nearly Sunday wrapped up. Here’s some of the stories we published on irishexaminer.com today which we hope will help you make sense of it all this evening.

Last week, the pharmaceuticals giant Johnson & Johnson was ordered to pay just over $570m (€518m) in compensation by a court in the south western US state of Oklahoma. Irony of ironies, the company’s share price rose following the news, the markets having anticipated that the award would be even higher.

Students can look forward to a healthy jobs market for the foreseeable future according to Ken Murphy of CareerWise Recruitment who says the market for graduates and others with qualifications has rarely been as healthy with many sectors at near full employment.

A classy extension, hi-spec decor, and a great location make this family home a winner, writes Trish Dromey.

Johnson & Johnson has agreed to pay about $1bn (€893m) to resolve most lawsuits claiming it sold defective metal-on-metal hips that had to be removed, according to people with knowledge of the matter.

Three months ago, Johnson & Johnson (J&J) predicted an ugly 2019 as the healthcare giant faced thousands of consumer lawsuits and pressure in the US on drug prices.

Retention of existing staff has become every bit as significant a priority as recruiting new talent, remarks John O’Neill, the vice-president of quality control with Janssen Phamaceutical.

Johnson & Johnson plans to create an additional 100 jobs as part of a €100m expansion of its Vision Care facility in Limerick.

Johnson & Johnson have announced they are to create an additional 300 jobs in a €100m expansion of the company’s Vision Care facilities, at the National Technology Park, Limerick.

Bayer and Johnson & Johnson have agreed to settle more than 25,000 US lawsuits alleging that their blockbuster blood thinner Xarelto caused unstoppable and in some cases fatal bleeding, court documents showed.

Pre-tax profits at the Irish arm of the maker of such popular consumer health products as Calpol, Benylin, and Listerine increased by 3% to €5.3m in 2017.

DePuy Synthes Ireland is to invest €36 million in ground-breaking research and development projects at its Innovation Centre, Loughbeg, Ringaskiddy, Co Cork.

Pharmaceutical companies GlaxoSmithKline (GSK) and Pfizer have said that it is too early to say what the implications are for their Irish staff after a partnership between the firms to create a €10.85bn consumer health division.

Oxfam has called for swifter action against tax avoidance by multinationals after its research showed pharmaceutical firms used Irish tax law to reduce the amount of corporation tax they paid — to zero in one case.